Parkinson DiseaseOLIMPIANCT06907589
A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care
A study testing Motor Data Analysis in people with Parkinson Disease and Healthy Adult, run by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna at 5 sites in Italy.
Trial summary
The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo… Read more about this study
- Who is it for?
- Ages 50 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Parkinson Disease, Healthy Adult
- What is being tested?
- Motor Data Analysis
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 250 participants
- Where
- 5 sitesItaly
- Study dates
- 13 May 2024to 8 Jan 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy subjects - Inclusion Criteria:
- Adult subjects, both sexes, aged 50-80 years old
- MMSE score >= 24 absence of olfactory deficit detected on IOIT olfactory test (22). Age class 50-59 years: normal with score <=5; age class 60-69 years: normal with score <=6; age class > 70 years: normal with score <=7
- absence of neurological diseases
- absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
- expression of informed consent to participate in the study
Show all 13Show fewer
- Subjects with Parkinson's disease -- Inclusion criteria:
- adult subjects, both sexes, 50-80 years of age
- MMSE score >= 24
- subjects with Parkinson's disease in the absence of motor fluctuations and dyskinesias, or subjects with Parkinson's disease with mild motor fluctuations throughout the day, but to be examined in the ON phase and in the absence of dyskinesias
- Hoehn and Yahr stage 1, 2, 3
- absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
- expression of informed consent to participate in the study
Who cannot join
- Healthy subjects - Exclusion criteria:
- denial of informed consent to participate in the study
- Presence of olfactory deficit detected on IOIT olfactory test. Age class 50-59 years: hyposmia with score >=6; age class 60-69 years: hyposmia with score >=7; age class > 70 years: hyposmia with score >=8
- body weight greater than 120 kg
- insufficient degree of cooperation
- malignant neoplasm in progress or with negative follow-up of less than 6 years
Show all 34Show fewer
- structured joint stiffness in the upper and/or lower extremities preventing proper execution of movements
- paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury
- mono/multi/poly sensory and/or motor neuropathy
- chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
- vertiginous syndromes in the acute phase
- neurodegenerative diseases
- fever
- venous thrombosis
- cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
- spinal or joint pain of various etiologies that may affect the performance of motor exercises
- positive history of recurrent acute cervico-brachialgia and/or lumbosciatica
- Subjects with Parkinson's disease - Exclusion criteria:
- Denial of informed consent to participate in the study
- Hoenn and Yahr stage 4, 5
- Patient who needs to use an aid (cane or walker) while walking or cannot walk unless aided by a person
- body weight greater than 120 kg
- insufficient degree of cooperation
- malignant neoplasm in place or with negative follow-up of less than 6 years
- structured joint stiffness in the upper and/or lower extremities that prevents proper execution of movements
- paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury mono/multi/poly sensory and/or motor neuropathy
- chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
- vertiginous syndromes in the acute phase
- neurodegenerative diseases, excluding Parkinson's disease
- fever
- venous thrombosis
- cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
- spinal or joint pain of various etiologies that may affect the performance of motor exercises
- positive history of recurrent acute cervico-brachialgia and/or low back pain
Trial locations and contacts
5 sites in 1 country. Contact the study team or a site near you to ask about taking part.
5 sites in 1 country
Italy5 sites, 5 recruiting
- Recruiting
Ospedale Santa Maria Annunziata AUSL Toscana Centro
Bagno a Ripoli, Firenze, 50012
Paola Vanni, +390552313862, paola.vanni@uslcentro.toscana.it
- Recruiting
Azienda Ospedaliero Universitaria Careggi
Florence, 50134
Silvia Ramat, +390557947956, silvia.ramat@unifi.it
- Recruiting
IRCCS Fondazione Don Carlo Gnocchi Firenze
Florence, 50143
Gemma Lombardi, +3905557393917, glombardi@dongnocchi.it
- Recruiting
Ospedale Apuane AUSL Toscana Nord Ovest
Massa, 54100
Carlo Maremmani, +3905854931, carlo.maremmani@uslnordovest.toscana.it
- Recruiting
IRCCS Istituto Auxologico Italiano, Ospedale San Luca
Milan, 20149
Andrea Ciammola, +39026191129, a.ciammola@auxologico.it
About this study
The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo drug-naïve extrapyramidal syndrome. The purpose is to identify normative data of objective motor measures obtained with such a system, as well as to increase knowledge about the potential contribution such a solution can make to the preclinical diagnosis of Parkinson's disease and the management of patients with this disease.
- Conditions
- Parkinson Disease, Healthy Adult
- Being tested
- Motor Data Analysis
- Keywords
- parkinson&#39;s disease, wearable sensors, motor data
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Motor Data AnalysisDevice
The SensMode System includes wearable devices for upper and lower limb motion analysis. The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist. Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field. The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.
| Study group | Role | What they receive |
|---|---|---|
| Motor Data Analysis for Healthy Subjects | Experimental | All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement Receives: Device: Motor Data Analysis |
| Motor Data Analysis for patients with Parkinson's disease | Experimental | All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement Receives: Device: Motor Data Analysis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of repetitions
Number of repetitions in Finger Tapping task
Measured: at Enrollment (T0)
Number of repetitions
Number of repetitions in Thumb-ForeFinger Tapping task
Measured: at Enrollment (T0)
Number of repetitions
Number of repetitions in Opening/Closing task
Measured: at Enrollment (T0)
Number of repetitions
Number of repetitions in Pronosupination task
Measured: at Enrollment (T0)
Number of repetitions
Number of repetitions in Toe Tapping task
Measured: at Enrollment (T0)
Number of repetitions
Number of repetitions in Leg Agility task
Measured: at Enrollment (T0)
Number of repetitions
Number of repetitions in Heel Tapping task
Measured: at Enrollment (T0)
Number of repetitions
Number of repetitions in Heel-Toe Tapping task
Measured: at Enrollment (T0)
Time to Stand Up
Time to stand up from a chair
Measured: at Enrollment (T0)
Gait Time
Time to walk for 15 meters straight on
Measured: at Enrollment (T0)
Rotation Time
Time to perform a turning of 360°
Measured: at Enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for hands resting tremor task
Measured: At enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for feet resting tremor task
Measured: At enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for hands postural tremor task
Measured: At enrollment (T0)
Fundamental frequency of accelerometer signal
Fundamental frequency of accelerometer signal for hands kinetic tremor task
Measured: At enrollment (T0)
Strides Number
Number of strides to walk for 15 meters straight on
Measured: at Enrollment (T0)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Apr 2025
- Study start13 May 2024
- Primary completionJan 2026 (estimated)
- Study completion8 Jan 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 250 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Filippo Cavallo, Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06907589
- Sponsor's protocol ID
- OLIMPIA
- Acronym
- OLIMPIA
- Status last verified
- Mar 2025
- First submitted
- 26 Mar 2025
- Last updated
- 2 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care
- ClinicalTrials.gov ID
- NCT06907589
- Acronym / sponsor ID
- OLIMPIA / OLIMPIA
- Conditions
- Parkinson Disease, Healthy Adult
- Keywords
- parkinson&#39;s disease, wearable sensors, motor data
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 250 participants (estimated)
- Lead sponsor
- Scuola Superiore di Studi Universitari e di Perfezionamento Sant'AnnaUniversity, hospital or other
- Study start
- 13 May 2024 (actual)
- Primary completion
- Jan 2026 (estimated)
- Study completion
- 8 Jan 2026 (estimated)
- First posted
- 2 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo drug-naïve extrapyramidal syndrome. The purpose is to identify normative data of objective motor measures obtained with such a system, as well as to increase knowledge about the potential contribution such a solution can make to the preclinical diagnosis of Parkinson's disease and the management of patients with this disease.
Study design
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Motor Data Analysis for Healthy Subjects | Experimental | Device: Motor Data AnalysisAll subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement |
| Motor Data Analysis for patients with Parkinson's disease | Experimental | Device: Motor Data AnalysisAll subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement |
Who may qualify
- Ages
- 50 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (13 listed)
- Healthy subjects - Inclusion Criteria:
- Subjects with Parkinson's disease -- Inclusion criteria:
Key exclusion criteria (34 listed)
- Healthy subjects - Exclusion criteria:
- Subjects with Parkinson's disease - Exclusion criteria:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Motor Data AnalysisThe SensMode System includes wearable devices for upper and lower limb motion analysis. The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist. Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field. The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe. | Device | Motor Data Analysis for Healthy Subjects, Motor Data Analysis for patients with Parkinson's disease |
Primary outcome
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Finger Tapping task
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Thumb-ForeFinger Tapping task
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Opening/Closing task
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Pronosupination task
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Toe Tapping task
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Leg Agility task
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Heel Tapping task
Number of repetitions
Time frame: at Enrollment (T0)
Number of repetitions in Heel-Toe Tapping task
Time to Stand Up
Time frame: at Enrollment (T0)
Time to stand up from a chair
Gait Time
Time frame: at Enrollment (T0)
Time to walk for 15 meters straight on
Rotation Time
Time frame: at Enrollment (T0)
Time to perform a turning of 360°
Fundamental frequency of accelerometer signal
Time frame: At enrollment (T0)
Fundamental frequency of accelerometer signal for hands resting tremor task
Fundamental frequency of accelerometer signal
Time frame: At enrollment (T0)
Fundamental frequency of accelerometer signal for feet resting tremor task
Fundamental frequency of accelerometer signal
Time frame: At enrollment (T0)
Fundamental frequency of accelerometer signal for hands postural tremor task
Fundamental frequency of accelerometer signal
Time frame: At enrollment (T0)
Fundamental frequency of accelerometer signal for hands kinetic tremor task
Strides Number
Time frame: at Enrollment (T0)
Number of strides to walk for 15 meters straight on
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
5 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Motor Data Analysis in people with Parkinson Disease and Healthy Adult, run by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna at 5 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 13 inclusion and 34 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 5 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Filippo Cavallo (+390552758663, filippo.cavallo@santannapisa.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of repetitions (time frame: at Enrollment (T0)). The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.